Dr Bridget Anne Thill, MD | |
300 Twining Street, Family Practice Clinic, Maxwell Afb, AL 36112 | |
(334) 953-1714 | |
Not Available |
Full Name | Dr Bridget Anne Thill |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 300 Twining Street, Maxwell Afb, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477549202 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 0101225849 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Bridget Anne Thill, MD 300 South Twining Street, Family Practice Clinic, Maxwell Afb, AL 36112 Ph: (334) 953-1714 | Dr Bridget Anne Thill, MD 300 Twining Street, Family Practice Clinic, Maxwell Afb, AL 36112 Ph: (334) 953-1714 |
News Archive
Research findings that can likely be used to develop a new type of medicine for type 2 diabetes are published today in the Journal of Cell Biology. Researchers at Stockholm University have discovered a new mechanism that stimulates glucose uptake in brown fat - a tissue whose primary function is to generate heat by burning fat and sugar.
MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today provided a clinical development update for Perceiva, the company's proprietary ocular sirolimus product.
A highly contagious SARS-CoV-2 variant was unknowingly spreading for months in the United States by October 2020, according to a new study from researchers with The University of Texas at Austin COVID-19 Modeling Consortium.
Most cancer drugs are designed to target dividing cells, but a new study by Stony Brook University researchers suggests that targeting invasive cells may be a new strategy to treat metastatic cancer.
Massachusetts General Hospital (MGH) and the Iacocca Foundation announce today the completion of the Phase I BCG clinical trial in type 1 diabetes, as well as the submission of all safety reports to the U.S. Food and Drug Administration (FDA) and the MGH data safety monitoring boards. Plans for the Phase II clinical study, which will continue the investigation of bacillus Calmette-Guerin (BCG) vaccination as a treatment for people with existing type 1 diabetes, are actively underway.
› Verified 5 days ago
Dr. Andrea Rae Bartlett, DO General Practice Medicare: Medicare Enrolled Practice Location: 300 Twining St Bldg 760, Maxwell Afb, AL 36112 Phone: 334-953-5200 | |
Dr. Jade Spurgeon, MD General Practice Medicare: Medicare Enrolled Practice Location: 300 Twining St, Building 760, Maxwell Afb, AL 36112 Phone: 334-953-9334 | |
Andrew Gieger, MD General Practice Medicare: Medicare Enrolled Practice Location: 300 Twining St Bldg 760, Maxwell Afb, AL 36112 Phone: 334-953-5200 Fax: 334-953-8607 | |
Dr. Erika Jean Anderson, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 300 Twining St Bldg 760, Maxwell Afb, AL 36112 Phone: 334-953-3368 |